Loading…
Biofrontera Inc. is projected to rise to $1.41 by 2027, a +18% move from its current price of $1.19. BFRI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.15 | $1.19 | $1.24 | +0.12% |
| Aug 6 | $1.13 | $1.19 | $1.26 | +0.23% |
| Aug 7 | $1.12 | $1.19 | $1.27 | +0.35% |
| Aug 8 | $1.11 | $1.20 | $1.29 | +0.46% |
| Aug 9 | $1.10 | $1.20 | $1.30 | +0.58% |
| Aug 10 | $1.09 | $1.20 | $1.31 | +0.69% |
| Aug 11 | $1.09 | $1.20 | $1.33 | +0.81% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.09 | $1.20 | $1.33 | +0.81% |
| Week 2 | $1.05 | $1.21 | $1.39 | +1.63% |
| Week 3 | $1.03 | $1.22 | $1.45 | +2.45% |
| Week 4 | $1.01 | $1.23 | $1.50 | +3.28% |
| Week 5 | $0.991 | $1.24 | $1.55 | +4.11% |
| Week 6 | $0.978 | $1.25 | $1.60 | +4.96% |
| Week 7 | $0.9668 | $1.26 | $1.64 | +5.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Biofrontera Inc. is a biopharmaceutical company that engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, a pre-cancerous skin condition.
The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Biofrontera Inc. (BFRI) is currently priced at $1.17 and has a market capitalization of $14.98M, ranking 4956 by market size. These figures place the stock as a small-cap asset with significant room for volatility relative to larger peers.
The price outlook shows a path of potential gains over the multi-year horizon, with year-by-year projections indicating a rising average price and sizable upside in later years.
A major floor 34.5% below — a decisive break under it would weaken the trend.
The nearest floor, 20.5% below — buyers have tended to step in here.
The nearest ceiling, 3.4% above — a clean break opens room to run.
A major ceiling 17.6% above — clearing it would confirm fresh momentum.
Key BFRI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BFRI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.15 | Buy | $1.16 | Buy |
| MA 10 | $1.11 | Buy | $1.13 | Buy |
| MA 20 | $1.11 | Buy | $1.10 | Buy |
| MA 50 | $1.01 | Buy | $1.05 | Buy |
| MA 100 | $0.9913 | Buy | $1.00 | Buy |
| MA 200 | $0.934 | Buy | $0.9742 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.71 | Neutral |
| Stoch RSI (14) | 55.16 | Neutral |
| CCI (20) | 100.36 | Buy |
| Williams %R (14) | -33.33 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 7.34 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 66.67 | Neutral |
| TRIX (15) | 0.45 | Buy |
| Awesome (5,34) | 0.08 | Buy |
| Ultimate (7,14,28) | 61.27 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 1.21 | Sell |
| ADX (14) | 13.96 | Neutral |
| ATR (14) | 0.04 | Info |
The near-term technical picture is bullish in sentiment, with RSI14 at 60 and price action supported by trending momentum. The 50-day simple moving average is $0.9908 and the 200-day simple moving average is $0.9315, suggesting a constructive trend. Immediate support sits at $0.946 and resistance at $1.17, while the 30-day range spans from $0.9157 to $1.49, underscoring notable volatility within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.725 | $1.19 | $1.66 | 0% | Neutral | |
| $1.08 | $1.41 | $1.95 | +18% | Neutral | |
| $1.12 | $1.51 | $2.21 | +27% | Bullish | |
| $1.28 | $1.79 | $2.72 | +51% | Bullish | |
| $1.41 | $2.03 | $3.17 | +70% | Bullish | |
| $1.82 | $2.70 | $4.34 | +127% | Bullish | |
| $2.17 | $3.31 | $5.44 | +178% | Bullish | |
| $2.28 | $3.56 | $6.00 | +199% | Bullish | |
| $2.30 | $3.68 | $6.32 | +209% | Bullish | |
| $2.18 | $3.56 | $6.24 | +200% | Bullish | |
| $3.73 | $6.78 | $12.82 | +470% | Bullish | |
| $7.47 | $16.44 | $34.69 | +12.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.725 | $1.19 | $1.48 | +0.00% |
| September 2026 | $1.08 | $1.29 | $1.60 | +8.77% |
| October 2026 | $1.10 | $1.32 | $1.66 | +2.12% |
| November 2026 | $1.06 | $1.28 | $1.63 | -2.87% |
| December 2026 | $1.05 | $1.29 | $1.66 | +0.63% |
Click any year to see its month-by-month BFRI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BFRI to range from $0.725 to $1.66 through 2026. The $1.19 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BFRI price prediction for 2027 points to an average of $1.41 (low $1.08, high $1.95) — a potential gain of +18% on today's $1.19. A consolidation phase looks the most probable path here.
In 2028, BFRI is projected to trade between $1.12 and $2.21, averaging $1.51 — a potential gain of +27% from today's $1.19. That is up +8% on the projected 2027 average. Momentum favours further upside here.
Biofrontera Inc.'s 2029 outlook centres on $1.79, within a $1.28 to $2.72 range. That is up +18% on the projected 2028 average. That marks a +51% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BFRI could reach as high as $3.17, with a base case around $2.03 and support toward $1.41 — roughly +70% from $1.19. Momentum favours further upside here.
Expect BFRI to range from $1.82 to $4.34 through 2031. The $2.70 average target implies a +127% move from current prices. That is up +33% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BFRI price prediction for 2032 points to an average of $3.31 (low $2.17, high $5.44) — a potential gain of +178% on today's $1.19. Momentum favours further upside here.
In 2033, BFRI is projected to trade between $2.28 and $6.00, averaging $3.56 — a potential gain of +199% from today's $1.19. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Biofrontera Inc.'s 2034 outlook centres on $3.68, within a $2.30 to $6.32 range. That is up +3% on the projected 2033 average. That marks a +209% change versus current levels. Momentum favours further upside here.
By 2035, BFRI could reach as high as $6.24, with a base case around $3.56 and support toward $2.18 — roughly +200% from $1.19. Buyers look set to stay in control over this stretch.
Expect BFRI to range from $3.73 to $12.82 through 2040. The $6.78 average target implies a +470% move from current prices. That is up +90% on the projected 2035 average. Momentum favours further upside here.
The BFRI price prediction for 2050 points to an average of $16.44 (low $7.47, high $34.69) — a potential gain of +12.8x on today's $1.19. Buyers look set to stay in control over this stretch.
Investing $1,000 in BFRI today (≈ 840.336134 BFRI) could be worth
$13,812
+$12,812 (+1281%) by 2050 · US Dollar
Based on the average projected BFRI price of $16.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BFRIwould be worth at today's price.
$1,000 invested in BFRI on Jul 31, 2025 (≈ 925.925889 BFRI) would be worth
$1,101.85
+$101.85 (+10.2%) today · 1.10× · US Dollar
Based on a BFRI entry price of $1.08 vs. today's $1.19.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.09 | $1,091.74 | +9.2% |
| 1 month ago | $1.01 | $1,178.22 | +17.8% |
| 3 months ago | $1.08 | $1,101.85 | +10.2% |
| 6 months ago | $0.896 | $1,328.12 | +32.8% |
| 1 year ago | $1.08 | $1,101.85 | +10.2% |
| All time (4.8y) ago | $88.2 | $13.49 | -98.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BFRI forecast.
Our base-case forecast reaches $2.40 around 2031.
Implied market cap at $2.40: $30.73M
The multi-year forecast shows a rising trajectory in average price across the years. In 2026 the avg is $1.17 with a 0% ROI and neutral sentiment. By 2027 the avg rises to $1.39 with a 19.2% ROI and neutral sentiment, and it continues higher in 2028 ($1.50, 28.2% ROI, bullish) and 2029 ($1.81, 54.6% ROI, bullish).
By 2030 the avg is $2.04 with a 74.1% ROI and bullish sentiment, expanding further to $2.71 (2031), $3.36 (2032) and $3.58 (2033), all with bullish sentiment. The forecast projects substantial upside later in the horizon, with 2040 avg $6.92 and 491.5% ROI, and 2050 avg $16.99 with 1351.8% ROI, both bullish, illustrating a long-term growth trajectory while acknowledging the uncertainty inherent in such projections.
Tap a question to reveal the answer.
Avg $2.04, min $1.42, max $3.17, ROI 74.1%, sentiment BULLISH.
Yes. The 2032 forecast shows max $5.51 and avg $3.36, with sentiment BULLISH.
The long-term outlook is bullish from 2027 onward, with rising averages and positive ROI in multiple years (e.g., 2040 ROI 491.5% and 2050 ROI 1351.8%), but 2026 reflects neutral sentiment and these figures are estimates, not guarantees.
Current price $1.17; Market cap $14.98M.
Low $0.9157, High $1.49 over the past 30 days.
Biofrontera Inc. Community Discussion
0Share your Biofrontera Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.